Clinical Trial Detail

NCT ID NCT01933815
Title Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cortice Biosciences, Inc.
Indications

glioblastoma multiforme

Therapies

Bevacizumab

TPI 287

Age Groups: adult

No variant requirements are available.